Top Markets
Coin of the day
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
Rang in aandelen #26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
Aandeelprijs
$0.12164306
Laatst gesynchroniseerd: 2024-11-11
Marktkapitalisatie
$38.53M
Verandering (1 dag)
-4.14%
Verandering (1 jaar)
0.00%
Land
AU
Handel PharmAust Limited (PAA)

Categorie

EPS voor PharmAust Limited (PAA)
EPS per June 2024 TTM: $-0.01
Volgens de laatste financiële rapporten en de aandelenkoers van PharmAust Limited is de huidige EPS van het bedrijf (TTM) $-0.01. Eind 2023 had het bedrijf een EPS van $-0.01, een daling ten opzichte van de EPS van 2022 die $0.00 bedroeg.
EPS-geschiedenis van PharmAust Limited van 2001 tot 2026
EPS aan het einde van elk jaar
Jaar EPS Wijzigen
2026 (TTM) $-0.01 -41.50%
2024 $-0.02 26.36%
2023 $-0.01 248.65%
2022 0.00 19.35%
2021 0.00 -3.13%
2020 0.00 -36.00%
2019 $-0.01 -60.63%
2018 $-0.01 53.01%
2017 $-0.01 -73.82%
2016 $-0.03 61.73%
2015 $-0.02 4.81%
2014 $-0.02 23.03%
2013 $-0.02 -90.70%
2012 $-0.16 -57.64%
2011 $-0.39 1,413.73%
2010 $-0.03 142.86%
2009 $-0.01 -97.72%
2008 $-0.46 -48.36%
2007 $-0.89 96.82%
2006 $-0.45 -40.46%
2005 $-0.76 -18.86%
2004 $-0.94 -11.50%
2003 $-1.06 -45.34%
2002 $-1.94 47.75%
2001 $-1.31 0.00%
EPS van vergelijkbare bedrijven of concurrenten
Bedrijf EPS EPS-verschil Land
$17.32 -148,134.19%
US
$27.74 -237,194.02%
NL
$2.98 -25,570.09%
AU
$-7.98 68,105.13%
US
- -
CH